Adventris Pharmaceuticals
Adventris makes cancer vaccines
Baltimore, United States · Founded 2022
- Headquarters
- Baltimore, Maryland
- Employees
- 1–10
- Founded
- 2022
- Website
- adventris.com
- Last Round
- Convertible NoteJan 2023
- Rounds
- 1
About
Adventris makes cancer vaccines. Our platform solves the problem of targeting poorly immunogenic oncogenes. Our first "off-the-shelf" vaccine targets KRAS, the most common cancer oncogene. In the long run, we envision a world where every adult receives our pan-cancer vaccines annually – preventing the majority of cancer deaths. If you are interested in learning more about our approach to treat and prevent cancer, please reach out to us at contact@adventris.com
Summary
Adventris Pharmaceuticals is a Biotech company based in Baltimore, United States, founded in 2022. Its most recent funding was a Convertible Note round in Jan 2023. Investors include Y Combinator and Refactor Capital.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
2023 (est.)
Investors
Similar Companies
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/adventris-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/adventris-pharmaceuticals" alt="Adventris Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>